🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect of Local Corticosteroid Injection in Carpal Tunnel Syndrome Patients With Type 2 Diabetes

Recruitingn/aAges 18 Years - 75 YearsAllHaydarpasa Numune Training and Research Hospital
NCT07433257 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Our study was planned as a prospective observational study aiming to compare the post-intervention recovery process between patients with carpal tunnel syndrome (CTS) and diabetes mellitus and patients with idiopathic carpal tunnel syndrome without diabetes mellitus. Patients who presented to the Physical Medicine and Rehabilitation outpatient clinic with clinical symptoms consistent with carpal tunnel syndrome and who were diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological findings and who received corticosteroid + local anesthetic injection will be included in the study. Data from patients who meet the inclusion and exclusion criteria will be included in the study. Patients' demographic and clinical data will be recorded. Records will be taken before treatment and at 4 and 12 weeks after treatment.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria * Carpal Tunnel Syndrome with Type 2 Diabetes Mellitus Group (Group 1): * Age between 18 and 75 years * Presence of clinical symptoms compatible with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months * Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings * Diagnosis of type 2 diabetes mellitus * Regulated blood glucose levels, defined as hemoglobin A1c (HbA1c) \< 7% * Idiopathic Carpal Tunnel Syndrome Group (Group 2): * Age between 18 and 75 years * Presence of clinical symptoms consistent with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months * Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings * No diagnosis of diabetes mellitus Exclusion Criteria * Severe carpal tunnel syndrome based on electrophysiological findings * Presence of polyneuropathy, cervical radiculopathy, brachial plexopathy, or thoracic outlet syndrome * Uncontrolled blood glucose levels in the diabetic group (hemoglobin A1c ≥ 7%) * Presence of another systemic disease, other than diabetes mellitus, that may cause carpal tunnel syndrome * Presence of a rheumatological disease * History of wrist surgery * Less than 6 months since a local corticosteroid injection for carpal tunnel syndrome * Less than 3 months since completion of a physical therapy program for carpal tunnel syndrome * Infection at the intended injection site * Presence of malignancy * Pregnancy
💊

What it tests

  • 1 mL 40 mg [40 mg/mL] triamcinolone acetonide + 1 mL 2% lidocaine hydrochloride
📍

Where

1 site
Istanbul Haydarpasa Numune Training and Research Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy